Eligible Companies for Exchange

Genesis Therapeutics is a developer of a computational platform focused on discovering small-molecule drugs. The company utilizes its proprietary molecular AI technology to advance the discovery and development of innovative drugs aimed at treating patients with severe and debilitating diseases. This approach empowers the medical community to enhance and optimize clinical outcomes for patients.

Ginger is the creator of a digital healthcare platform that is designed to deliver immediate mental health support on-demand. Ginger's platform provides chat support from a trained behavioral health coach and video consultations with licensed therapists or psychiatrists, allowing patients to access instant personal assistance and obtain real-time mental health feedback.

Graviton BioScience is a developer of clinical-stage drugs aimed at treating autoimmune disorders, cancer, and other severe diseases. The company's platform is focused on designing and advancing therapeutics for CNS, autoimmune, fibrotic, and various serious conditions where ROCK2 and its other compounds are crucial in disease pathology. Graviton BioScience offers drug candidates targeting Rho-associated protein kinase, a significant mediator of cellular contractility and fibrosis. This enables customers to potentially access revolutionary treatments for a variety of debilitating illnesses.

H1 Insights operates a healthcare data analytics platform designed to help companies make informed scientific choices. H1 Insights' platform offers real-time data to support the complete therapeutic development process ranging from fundraising, product development to product launch. This provides the healthcare industry, organizations, and professionals with live, on-demand insights from a myriad data sources. This accelerates the process of discovering and developing therapies to combat diseases.

Harbinger Health develops innovative health technology focused on the early detection of cancer. The company offers a specialized blood test that leverages artificial intelligence and machine learning for early cancer diagnosis, allowing healthcare professionals to identify cancer before symptoms manifest.

Headspace, a developer of a mental health application, focuses on promoting mindfulness and emotional well-being. The platform provides a range of guided meditations, sleep aids, and mindfulness exercises, allowing individuals to effectively manage stress and anxiety. Headspace aims to enhance overall mental health by offering accessible resources tailored for users seeking personal growth and an improved quality of life.

Headway operates a mental healthcare platform designed to offer users affordable access to professional help when required. By managing a virtual network of therapists who accept insurance, Headway facilitates both video and in-person sessions that can be entirely booked online. This service enables healthcare providers to grow their practices while allowing individuals to save money on mental health consultations.

HealthTap, the creator of a virtual primary care platform, is committed to providing every American with an affordable, long-term primary care doctor equitably. Their services include regular texting with a doctor, video consultations, urgent care from the first available doctor, and free responses from a network of volunteer, U.S. doctors across various specialties to any health-related questions. HealthTap enables users to conveniently choose and retain their doctor to manage all their ongoing health needs.

HealthVerity has developed a healthcare data and patient informatics platform, which is engineered to enhance data discovery and distribution. The platform of this company handles the intricacies of scattered patient data, ensures accurate patient matching while maintaining de-identification, and facilitates the exchange of healthcare and consumer data in a unified space. This empowers healthcare organizations to establish patient journeys by connecting and swapping Real World Data (RWD) across the ecosystem.

HeartFlow is the creator of a cardiac diagnostic platform designed to revolutionize the diagnosis and treatment of coronary artery diseases. This platform utilizes data from regular computerized tomography scans to generate a personalized three-dimensional model of arteries. It further analyzes the effects of blockages on blood flow. This innovative approach enables clinicians to effectively treat patients suffering from significant coronary artery disease while minimizing unnecessary invasive testing.

Hello Heart has developed a health monitoring system that aids in self-diagnosing health conditions. The system includes a blood pressure monitor and a smartphone application, offering real-time personalized advice for conditions like hypertension, diabetes, and body weight issues. This enables users to self-manage hypertension, promote behavioral change, and prevent serious health risks.

Hexagon Bio has developed a synthetic biology platform that leverages data science to explore genomes for small molecule inhibitors targeting specific proteins. This platform integrates genomics, synthetic biology, and automation to uncover evolutionarily refined compounds and their protein targets directly from fungal genomes. By tapping into the global metagenome, Hexagon Bio aims to identify new medicinal compounds, facilitating the development of innovative treatments to enhance patient care.

HistoSonics is the creator of an innovative, non-intrusive sonic beam therapy platform designed to annihilate targeted tissues at a sub-cellular level by liquefying them. The company's platform provides custom, tissue-specific treatments with unmatched accuracy and control, devoid of the unwanted side effects commonly associated with current surgical and interventional methods. This allows physicians to consistently monitor the treatment and its impact in real time.

Honor, an operator of a home care network, is dedicated to providing professional and expert in-home care services for the elderly. Their unique approach combines scalable workforce management and advanced technology to offer personalized care through a system of collaborated third-party care providers. This enables older adults to live safely and comfortably in their own homes, ensuring they receive reliable, transparent, and high-quality care.

Human Longevity has developed a biotechnology platform that merges genomic and phenotypic information to expedite the comprehension of human health. The platform focuses on addressing the age-related decline in inherent stem cell function and diseases like cancer, diabetes and obesity, heart and liver conditions, and dementia. By integrating DNA sequencing and expert analysis with machine learning, Human Longevity's platform empowers individuals to influence their health and facilitates the shift from reactive to proactive medical practices.

Iambic Therapeutics has developed a cutting-edge quantum molecular simulation engine focused on expediting the discovery of new therapeutics. This innovative engine integrates AI-driven technology with automated synthesis processes to swiftly design small-molecule drugs. This enables healthcare professionals to achieve molecular predictions with significantly enhanced accuracy, transforming the landscape of drug discovery.

IDRx specializes in developing oncology-focused precision therapies aimed at transforming cancer treatment. The company creates precision combination therapies, featuring highly selective, engineered drug combinations that target key tumor escape mechanisms to extend therapeutic responses. This approach empowers healthcare professionals to create effective cancer treatments through purposefully crafted combinations, offering tailored cancer medicines for patients.

Immunai is a bioinformatics platform designed to improve our understanding of complex diseases and facilitate more effective targeted therapy development. By leveraging artificial intelligence, the platform analyzes extensive biological datasets and forecasts treatment outcomes, which empowers healthcare researchers to enhance drug discovery and development processes.

Imperative Care is a developer of innovative technology for stroke diagnosis, treatment, and rehabilitation, aiming to mitigate the debilitating effects of stroke on patients. The company's services enhance stroke treatment by pioneering advanced medical technology and providing healthcare providers with the tools to improve practices and raise the quality of care. This empowers stroke patients to access catheters for cardiovascular diagnosis.

Inceptive is a developer of a biological software development platform focused on creating synthetic molecules for intricate biological functions. The company innovates new medicines and biotechnologies, allowing clients to achieve healthcare and biotech advancements that were once out of reach.

Incredible Health, a creator of an online recruitment platform, is designed to support medical professionals in securing positions within healthcare organizations. The company's subscription-based job site allows users to streamline their job search process, get job alerts and notifications, apply for interviews, and receive career guidance from recruitment specialists. This platform empowers new graduates, unemployed medical staff, practicing doctors, and nurses to secure employment.

Infinitus Systems has developed a healthcare AI communication tool that streamlines communication by automating tedious and time-consuming phone calls with precision and easily trackable updates. The tool allows users to effortlessly submit call requests to the system, which then queues the tasks. Users are promptly notified upon task completion and can also choose to collect results in bulk at their convenience.

Innovaccer, a developer of a technological platform, is dedicated to revolutionizing and enhancing healthcare delivery. The company's platform amasses, scrutinizes, and utilizes patient data from a multitude of sources including electronic health records (EHRs), medical devices, and other systems. It fosters communication and cooperation among teams and provides tools for managing billing, claims processing, and reimbursement to maximize financial operations and alleviate administrative pressures. This enables healthcare organizations to simplify clinical workflows, augment care coordination, and ameliorate patient outcomes.

Inscripta has developed a gene-editing technology that provides scalable digital genome engineering with straightforward simplicity. Their technology creates affordable libraries of thousands of custom-made protein, pathway, or genome variants, each having specific and traceable mutations. This allows researchers to design, engineer, evaluate, and monitor results, making Inscripta's technology an essential tool in their field.

Insitro is a leader in the field of data-driven drug discovery and development, aiming to revolutionize the way drugs are discovered and supplied to patients. By employing machine learning and high-throughput biology, insitro generates vast data sets that tackle major obstacles in pharmaceutical R&D. This enables pharmaceutical companies to utilize predictive models that hasten the process of target selection, therapeutic design and development, and the formulation of clinical strategies.

IntelyCare has developed an intelligent healthcare workforce management platform that assists in hiring nursing and healthcare staff. The platform employs artificial intelligence to automate the scheduling and filling of shifts at nursing facilities, and to hire professionally qualified care relief staff. Additionally, IntelyCare's proprietary system automatically checks the status of nurses' and CNAs' state licenses, enabling hospitals and clinics to simplify and streamline their hiring processes.

InterVenn is the creator of a biomarker and target discovery platform that is designed to assist in the identification and prioritization of ovarian and other cancers. The platform developed by InterVenn concentrates on locating, quantifying, and categorizing glycoproteomic and PTM signals present in human blood and tissue for the purpose of target discovery and validation. This allows healthcare professionals to diagnose cancer at an early stage, thereby enhancing patient care.

K Health offers digital primary care services designed to connect global health data, enabling remote treatment. The company's platform analyzes how doctors diagnose and treat patients with similar symptoms and conditions. Users can access this information for free, chat with a doctor for less than a copay, and maintain a comprehensive record of their medical history. This allows patients to gain clinical insights and confidently seek answers or treatment.

Kallyope operates as a biotechnology firm whose mission is to discover and develop oral agents that are both effective and easy to use. The company employs a combination of technologies in sequencing, bioinformatics, neural imaging, cellular and molecular biology, and human genetics. Kallyope's in-depth understanding of gut-brain biology allows it to provide the healthcare sector with therapeutics designed to enhance human health.

Kindbody is a provider of comprehensive health and fertility services designed to enhance healthcare access for women. Kindbody's array of services spans the full spectrum of fertility assistance, adoption and surrogacy, and maternity care, as well as ongoing gynecology and holistic wellness. These services are offered using advanced technology at competitive prices, allowing patients to receive quality healthcare without breaking the bank.

Komodo Health is the creator of a healthcare technology platform that sets a new standard for real-world data and analytics. The company provides a comprehensive suite of robust software applications that produce patient-level insights by dynamically evaluating the widest range of data across patients, practitioners, and health systems. This enables health and life sciences enterprises to discover insights that inform decision-making, bridge care gaps, and lessen disease burden.

Kriya Therapeutics, a gene therapy company, is committed to the design and development of gene therapies for diseases with fundamental biological underpinnings. The company employs a vector design platform that enhances its ability to perform de novo construct design, targeted sequence modification and data analysis. This enables physicians to reduce immunogenicity and enhance tissue specificity.

KSQ develops transformative medicines designed to accurately target the key nodes of disease. The company's industrialized functional genomics engine employs a range of tools to identify novel pathways and targets in oncology and immuno-oncology. This enables doctors to discover new drug targets, understand mechanisms of drug efficacy, and identify transformative single-agent and combination therapies to benefit patients.

Lark has developed a virtual platform for chronic disease prevention and management that aims to make healthy living attainable, accessible, and affordable. The platform leverages artificial intelligence to offer personalized, real-time support and counseling, complemented by human coaches and connected device technology. This enables individuals to make healthier lifestyle choices and effectively manage their chronic conditions.

Laronde is the developer of eRNA-based therapeutics, designed to create more reliable and powerful medicines for global use. The company's unique Endless RNA (eRNA) can be programmed to produce a variety of proteins within the body. It is characterized by its persistence, non-immunogenic properties, repeat dosing capabilities, and formulation and delivery flexibility. This enables healthcare professionals and medical companies to develop innovative therapeutics that are poised to become essential future medicines.

Levels has developed a wellness wearable designed to monitor metabolic fitness. This device offers real-time data, delivering immediate feedback on individual metabolism. It helps users quickly comprehend how their bodies react to dietary and lifestyle choices, empowering them to optimize their diets and routines to achieve personal goals.

LifeMine is the developer of a drug discovery platform designed to unravel human biology and craft advanced therapeutics targeting the core drivers of serious human diseases. Leveraging fungal biodiversity, the company's platform develops therapeutics that are both mechanistically and structurally novel, addressing previously insurmountable therapeutic challenges. By doing so, LifeMine enables healthcare providers to tackle difficult human diseases through innovative biological mechanisms.

LightForce has developed a customized three-dimensional printed orthodontic bracket system aimed at providing patient-specific digital dental treatment. Their product utilizes on-demand three-dimensional manufacturing to offer tailored treatment plans, representing a significant advancement in bracket-based treatment protocols. This innovation allows orthodontists to achieve unprecedented control, effectively addressing challenging clinical situations and improving treatment efficiency.

Loyal specializes in creating veterinary medications designed to enhance the health span and lifespan of dogs. The company's products aim to postpone the development of age-associated diseases such as cancer, heart disorders, and metabolic conditions, allowing dogs to enjoy longer and healthier lives.

Lumeris is a developer of a value-based care managed services platform designed to elevate clinical and financial outcomes for health systems. The platform fuses guidance, knowledge, and technology to enhance performance on a large scale, working together with health systems and physician groups nationwide. By adopting progressive risk management and value-based care capabilities along with innovative solutions, Lumeris allows healthcare providers to boost quality metrics, minimize costs linked to chronic diseases, and potentially provide superior health outcomes for patients.

Luna Physical Therapy operates a health and wellness center focused on delivering physical therapies. The company excels in offering treatments for orthopedic and sports-related injuries, senior care, post-surgical rehabilitation, and addressing back and neck pain. Additionally, they provide specialty care and targeted training, allowing patients better access to treatment. Therapists enjoy the independence and flexibility necessary to advance their careers and succeed in their practice.

Lycia Therapeutics is a biotechnology firm focused on discovering and developing innovative therapeutics. Utilizing its lysosomal targeting chimeras platform, the company aims to create treatments that degrade extracellular and membrane-bound proteins responsible for various challenging diseases, such as cancers and autoimmune disorders. This approach assists medical professionals in accessing drugs designed to treat and potentially cure these conditions.

Lyra, the creator of a revolutionary digital health platform, is aimed at revolutionizing mental health care by integrating technology with a personal touch. The platform links members with a carefully selected network of therapists and coaches through live video therapy, coaching, and digital self-care tools, resulting in quicker access to care and improved results compared to traditional plans. Lyra enables employers to provide care to their employees and families online with the same flexibility as in-person care.

Mammoth Biosciences, a biotechnology company, is focused on developing long-term curative therapies and decentralized precision diagnostics. Leveraging its proprietary ultracompact proteins for in vivo gene editing in hard-to-reach tissues, the company utilizes nuclease applications such as base editing, gene writing, and epigenetic editing, enabling healthcare professionals to enhance patient outcomes.

Marea is a biotechnology company focused on cardiometabolic diseases. Its primary initiative, MAR001, is currently in Phase 2 of clinical development. Marea is dedicated to creating innovative treatments for individuals at risk of heart attacks, aiming to address elevated remnant cholesterol and metabolic dysfunction.

Maze Therapeutics has designed a biotechnology platform that is centered on transforming genetic insights into innovative medicines. The platform integrates comprehensive human genetic data analysis, functional genomics, and a range of drug discovery techniques to identify modifier genes that offer protection. This facilitates a more profound understanding of target biology and how these targets can be effectively addressed with drug treatments. This enables pharmaceutical companies to create novel therapeutic options.

Medable is the developer of a cloud-based platform designed to deliver effective therapies to patients worldwide. Medable's platform encompasses modules such as back-end, analytics, collaboration, compliance, and research survey, all tailored to the strict compliance, interoperability, and privacy concerns of the global healthcare sector. This enables medical practitioners to simplify digital trials, expanding patient access and improving outcomes.

Medallion offers a licensing and credentialing platform tailored to streamline the paperwork demands of the healthcare sector. This platform features facilities for new licensing and renewals, complete with primary source verification, tracking of continuing medical education, document management, and payer enrollment. It aids healthcare providers and telemedicine companies in minimizing time spent on administrative tasks, allowing them to dedicate more time to patient care.